Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies
Open Access
- 14 December 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (24) , 9492
Abstract
Hypoxia, a common factor ruling the microenvironment composition, leads to tumor progression. In this hypoxic context, cytokines and cells cooperate to favor cancer development and metastasis. Tumor hypoxia is heterogeneously distributed. Oxygen gradients depend on the vicinity, functionality of blood vessels, and oxygen ability to diffuse into surrounding tissues. Thus, the vasculature state modulates the microenvironment of the tumor cells. Cells sense and react to small variations in oxygen tension, which explains the lack of tumor cells’ unicity in their reaction to drugs. Ovarian cancers are highly hypoxia-dependent, ascites worsening the access to oxygen, in their reactions to both chemotherapy and new immunotherapy. Consequently, hypoxia affects the results of immunotherapy, and is thus, crucial for the design of treatments. Controlling key immunosuppressive factors and receptors, as well as immune checkpoint molecule expression on tumor, immune and stromal cells, hypoxia induces immunosuppression. Consequently, new approaches to alleviate hypoxia in the tumor microenvironment bring promises for ovarian cancer immunotherapeutic strategies. This review focuses on the effects of hypoxia in the microenvironment and its consequences on tumor treatments. This opens the way to innovative combined treatments to the advantage of immunotherapy outcome in ovarian cancers.Keywords
Funding Information
- Narodowe Centrum Nauki (2012/07/N/NZ5/02052, OPUS2016/23/B/NZ6/02542, OPUS2016/23/B/NZ1/03211, 2017/26/E/NZ3/00434)
- Wojskowy Instytut Medyczny (1/8912(412))
This publication has 130 references indexed in Scilit:
- Stable tumor vessel normalization with pO2 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatmentJournal of Molecular Medicine, 2013
- The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressivenessBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
- Normalization of the tumor vasculature through oncogenic inhibition: An emerging paradigm in tumor biologyProceedings of the National Academy of Sciences, 2012
- Effects of HIF-1 and HIF2 on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 XenograftsJournal of Oncology, 2010
- Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expressionRadiation Oncology, 2009
- Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3International Journal of Cancer, 2009
- Prognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1alpha) expression in serous ovarian cancer: an immunohistochemical studyBMC Cancer, 2008
- Identifying symptoms of ovarian cancer: a qualitative and quantitative studyBJOG: An International Journal of Obstetrics & Gynaecology, 2008
- Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase PathwayMolecular Cell, 2008
- Frequency of Symptoms of Ovarian Cancer in Women Presenting to Primary Care ClinicsJAMA, 2004